Sector Expert: Stephen Reznik
Reznik Asset Managment
Stephen began his career with MetLife and Dean Witter before landing at Investment Management & Research (the forerunner to Raymond James Financial Services) in 1989. In only four years, he built one of the premier Raymond James offices in the country, becoming a member of the Chairman's Council in 1993.He built his practice with an intense focus on medical stock and utilizing what he calls the "Premium Equity Income Strategy." Over the years he built wealth for clients by finding winners in names like Amgen, Upjohn, Pharmacia, Chiron, and Celgene.
How Investors at the California Capital Conference Picked the Next Top Small-Cap Companies (12/7/15)
If only someone could bottle the experience of finding an overlooked company, investing for pennies a share and cashing in for 10, 20 or 30 times what you paid. Priceless, right? But how to find those companies? Small caps aren't covered by the mainstream press and analysts the way blue chips are, and determining value of an early-stage company before profit and loss statements take on real meaning and big questions about science and markets are answered can be difficult. That is why veteran investors like Tom Swaney, president of California-based Harwood Capital Inc., like to meet management in person at events like the California Capital Conference.